show that the API nelfinavir induces a secretory form of diarrhea in HIV-infected patients. In vitro studies demonstrate that nelfinavir potentiates muscarinic stimulation of Cl Ϫ secretion by T84 human intestinal cell monolayers through amplification and prolongation of an apical membrane Ca 2ϩ -dependent Cl Ϫ conductance. This stimulated ion secretion is associated with increased magnitude and duration of muscarinically induced intracellular Ca 2ϩ transients via activation of a long-lived, store-operated Ca 2ϩ entry pathway. The enhanced intracellular Ca 2ϩ signal is associated with uncoupling of the Cl Ϫ conductance from downregulatory intracellular mediators generated normally by muscarinic activation. These data show that APIs modulate Ca 2ϩ signaling in secretory epithelial cells and identify a novel target for treatment of clinically important API side effects.
nelfinavir; clotrimazole; barium ASPARTYL PROTEASE INHIBITORS (APIs) are important components of most highly active antiretroviral therapy (HAART) regimens used in the treatment of human immunodeficiency virus (HIV)-1 infection. These agents decrease plasma HIV viral load, increase peripheral CD4 ϩ T lymphocyte counts, delay clinical progression, and extend life expectancy (17) . However, the clinical utility of these agents has been limited by serious side effects, which include lipodystrophy, insulin resistance, and diarrhea (14) . The mechanistic bases of these dose-limiting side effects of API treatments remain unexplained.
In these studies, we examine the effects of the API nelfinavir on the intestine and on intestinal epithelial cells. Intestinal fluid secretion in the human depends on the closely regulated transport of Cl Ϫ ions by epithelial cells lining the intestinal crypt. Crypt epithelia utilize the basolateral membrane Na ϩ -K ϩ -ATPase and Na ϩ -and K ϩ -coupled cotransporter NKCC1 to accumulate intracellular Cl Ϫ above its electrochemical equilibrium potential. The regulated opening of apical membrane Cl Ϫ channels in that setting results in a net secretion of Cl Ϫ ions into the intestinal lumen. Coordinated opening of basolateral K ϩ channels to maintain an inside-negative membrane potential sustains the Cl Ϫ secretory response by enhancing both the electrical gradient favoring electrogenic apical Cl Ϫ exit and the chemical gradient favoring Na ϩ -and K ϩ -coupled Cl Ϫ uptake by basolateral NKCC1. Water and Na ϩ are thought to follow Cl Ϫ passively into the intestinal lumen to effect net fluid secretion.
Neural, endocrine, paracrine, and autocrine mechanisms tightly regulate intestinal fluid secretion in the human via agonists that utilize either cyclic nucleotides or Ca 2ϩ as second messengers. Agonists that depend on adenosine 3Ј,5Ј-cyclic monophosphate (cAMP) to initiate Cl Ϫ secretion activate the apical membrane Cl Ϫ channel CFTR (cystic fibrosis transmembrane receptor) and the basolateral membrane K ϩ channel KCNQ1/KCNE3 (2, 10, 32, 42 
METHODS
Clinical studies. Eight HIV-infected subjects (ages 21-54) with diarrhea (stool output Ն300 g/24 h) for longer than 1 mo while on nelfinavir-containing regimens were admitted for 48 h and received a controlled diet (ϳ4,200 calories/day: 50% carbohydrates, 12% protein, and 38% fat). Subjects remained on their prescribed daily dose of nelfinavir (5 subjects received 1,250 mg twice daily, and 3 three subjects received 750 mg 3 times daily). Antidiarrheal medications were discontinued 3 days before and during hospitalization. Subjects receiving APIs other than nelfinavir or with any condition known to cause diarrhea were excluded from study participation. Stool output was collected in preweighed containers and stored at 4°C. Specimens were weighed, homogenized, and centrifuged for 10 min at 2,000 rpm. Short-circuit measurement in intact monolayers. Short-circuit current (I sc) and transepithelial resistance were measured in confluent T84 cell monolayers grown on 0.33-cm 2 , 3-m-pore polycarbonate filter inserts (Costar, Cambridge MA) in symmetrical baths of Hanks' balanced salt solution (HBSS) containing 0.05% BSA at 37°C as previously described (40, 41) . Carbachol (CCh) was used at 100 M and forskolin at 10 M. We routinely observe a variability of 10-15 A/cm 2 in maximal Isc elicited by the muscarinic agonist CCh in T84 monolayers due to cell culture and plating of T84 cells on filter inserts from sequential passages, consistent with previous studies (28, 48 Table  1 ) as previously described (41) . Transmembrane potential was clamped at 0 mV, and I (bl)K was measured before and after stimulation with CCh. Apical Cl Ϫ conductances, measured as short-circuit current [I (ap)Cl], were studied in cells permeabilized basolaterally with 100 M amphotericin B, in the presence of symmetric high-Cl Ϫ buffer (solution 1) with transmembrane potential clamped at ϩ10 mV (apical) as previously described (34) . I (ap)Cl was measured before and after thapsigargin stimulation. Anion selectivity was measured in asymmetrical nelfinavir-containing buffers that imposed an apically directed ϳ20-fold gradient of either I Ϫ (basal solution 6, apical solution 7) or Cl Ϫ (basal solution 2, apical solution 3) as the sole permeant ions. Transepithelial currents were measured during 1-s voltage clamp periods ranging from Ϫ80 to ϩ80 mV and normalized to baseline Isc at rest as described (34) . Baseline current-voltage (I-V) curves obtained in the absence of agonist were subtracted from those measured after agonist treatment to calculate agonist-induced currents. Immunoblots of phospho-p38. T84 cell monolayers (grown on collagen-coated 5-cm 2 filters) were preincubated in the presence or absence of 30 M nelfinavir for 30 min at 37°C. After exposure to CCh (100 M) for the indicated intervals (between 0 and 15 min), monolayers were transferred into ice-cold lysis buffer (1 mM NaF, 1 mM sodium vanadate, 1% Triton X-100, one protease inhibitor MiniTab with EDTA; Hoffman-La Roche). Cell lysates were clarified by centrifugation, and phophorylated p38 was assayed by immunoblot.
IP 4 measurements. T84 cell monolayers (grown on collagen-coated 45-cm 2 filters) were labeled for 24 h in inositol-free DMEM containing 5% fetal calf serum and 5 Ci/ml [ 3 H]inositol. To ensure that cells were studied at steady state, we treated monolayers in the presence or absence of nelfinavir (40 M) during the final 2.5 h of labeling with [ 3 H]inositol. Three minutes after addition of CCh, inserts were transferred into ice-cold PBS, lysed in 10% trichloroacetic acid by repeated freeze-thaw cycles, and clarified by centrifugation. Total cell lipids were then extracted in H 2O-saturated ether, dried overnight, and analyzed by HPLC as previously described (39) .
Intracellular Ca 2ϩ measurements. T84 cells cultured at subconfluent density on collagen-coated 5-cm 2 coverslips were incubated at 37°C in growth medium containing 2 M fura 2-AM (Molecular Probes, Eugene, OR) for 30 min, washed, and mounted in a modified Leiden chamber. T84 clusters containing Ͼ20 fura 2-stained cells at the cluster periphery were selected, and the intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i) was measured in all stained cells within a single cluster by fura 2 fluorescence ratio imaging at 20°C in room air, as described previously (41) .
Statistical methods. Unless otherwise indicated, data were tested for statistical significance by ANOVA (StatView; SAS, Cary, NC). P Ͻ 0.05 was chosen to denote statistical significance.
RESULTS

Nelfinavir induces secretory diarrhea through selective potentiation of signaling by muscarinic and other Ca
2ϩ -dependent agonists. Stool samples collected from eight HIV-infected individuals on chronic nelfinavir therapy exhibited fecal electrolyte concentrations ([Na ϩ ] and [Cl Ϫ ]) consistent with a secretory process. Stool pH and the fecal supernatant osmotic gap were consistent with a secretory process in seven subjects (Table 2 ). These data show that HIV-1-infected patients on chronic nelfinavir therapy have a secretory diarrhea.
To examine the cellular mechanisms underlying this secretory defect, we utilized the human intestinal T84 cell line. T84 cells model regulated Cl Ϫ secretion in the human intestine (1). Exposure of resting T84 cells to nelfinavir (30 M) produced no detectable effect on Cl Ϫ secretion (I sc ) or transepithelial resistance. Nelfinavir-pretreated monolayers subsequently exposed to CCh showed a three-to fourfold increase in peak Cl Ϫ secretory response (Fig. 1A) and a prolonged duration of Cl Ϫ secretion (30 min after CCh exposure, I sc was 3.5 Ϯ 0.3 A/cm 2 in control and 9.1 Ϯ 0.83 A/cm 2 in nelfinavirpretreated monolayers, means Ϯ SE, n ϭ 7 experiments, P Յ 0.001). Nelfinavir pretreatment did not alter the decrease in transepithelial resistance observed after subsequent treatment with CCh (598 Ϯ 74 and 723 Ϯ 133 ⍀⅐cm 2 , means Ϯ SE, in control and nelfinavir-treated T84 cell monolayers, respectively). Nelfinavir had no effect on Cl Ϫ secretion elicited by the cAMP-dependent agonists vasoactive intestinal peptide (VIP; 5 nM) (Fig. 1 , B and E) or adenosine (10 M; see below). Stimulation of I sc by nelfinavir (at all tested concentrations) was observed only after CCh treatment (Fig. 1C) . The EC 50 value for nelfinavir was ϳ4-8 M after 30-min preincubations approximating the peak plasma concentration (4 mg/l or 6 M) measured in humans treated with 1,250 mg of nelfinavir twice daily (17) . Nelfinavir (30 M) did not change the EC 50 value of CCh, and the CCh-potentiating effect of nelfinavir was not reversed after 24 h (nelfinavir increased the peak response to CCh by 180%). Nelfinavir also potentiated the action of two other Ca 2ϩ -dependent secretagogues ( Fig. 1D ): thapsigargin (5 M) and the bile acid taurodeoxycholate (500 M). The effects of nelfinavir on agonist-stimulated I sc in T84 cells are summarized in Fig. 1E . The structurally related HIV APIs saquinavir and indinavir similarly potentiated muscarinic Cl Ϫ secretion in T84 cells (Fig. 2) . Nelfinavir pretreatment of the human intestinal cell line HT29 C119a also potentiated CChactivated I sc (data not shown). Thus nelfinavir and other APIs produce long-lasting stimulatory effects on I sc induced by Ca 2ϩ agonists in two human colonocyte cell lines.
Nelfinavir potentiates an apical Ca 2ϩ
-dependent Cl Ϫ conductance and uncouples it from downregulatory signals. We assessed the relative contributions of basolateral and apical conductances to nelfinavir-stimulated I sc by studying selectively permeabilized monolayers. To test stimulation of basolateral K ϩ channels, we permeabilized selectively the apical membranes of T84 cells with the ionophore amphotericin B, and the monolayer was exposed to an apical-to-basolateral K ϩ gradient with K ϩ as the sole permeant ion, as previously described (41) . After achievement of steady state, CCh was added and basolateral K ϩ conductance was measured as the short-circuit current I (bl)K . These apically permeabilized monolayers exhibited similar basolateral K ϩ conductances after muscarinic stimulation in the presence or absence of nelfinavir (Fig. 3, A and B) . Thus nelfinavir has no effect on basolateral K ϩ conductance activated by CCh stimulation (believed to be mediated by the Ca 2ϩ -dependent K ϩ channel IK1/KCNN4) (12) . Nonetheless, Cl Ϫ secretion elicited by nelfinavir requires basolateral K ϩ conductance and is blocked fully by high concentrations of the K ϩ channel inhibitor clotrimazole (Fig. 4) . Nelfinavir could also act by increasing the apical membrane Ca 2ϩ -dependent Cl Ϫ conductance or possibly (though less likely, in view of Fig. 1B ) through activation of the apical cAMP-dependent CFTR. We therefore permeabilized selectively the basolateral membrane of T84 cell monolayers with amphotericin B. Cells were then studied in symmetrical solutions containing Cl Ϫ as the only permeant ion, and apical Cl Ϫ conductance, measured as I (ap)Cl , was measured as previously described (41) . Basolateral permeabilization precludes the use of the muscarinic agonist CCh in studies assessing apical Ca 2ϩ -activated Cl Ϫ conductances. Thus we used the endoplasmic Ca 2ϩ -ATPase pump inhibitor thapsigargin in these experiments. These studies showed that thapsigargin-induced I (ap)Cl in basolaterally permeabilized T84 cell monolayers was significantly higher in cells pretreated with nelfinavir than in control cells (Fig. 5, A and B) .
To characterize further this nelfinavir-enhanced apical Cl Ϫ conductance, we compared apical Cl Ϫ and I Ϫ conductances of nelfinavir-pretreated, basolaterally permeabilized T84 cells before and after stimulation with thapsigargin or with the cAMP agonist forskolin. Thapsigargin-stimulated apical membrane current measured across nelfinavir-pretreated T84 monolayers in asymmetric I Ϫ solutions [I (ap)I ] was greater than thapsigargin-stimulated apical membrane current measured in asymmetric Cl Ϫ solutions [I (ap)Cl ]. This result was consistent with activation of an apical membrane Ca 2ϩ -gated Cl Ϫ conductance (although the reversal potential of the thapsigargin-stimulated currents suggested either substantial gluconate permeability of the anion conductance or substantial contribution of stimulated cation conductance) (Fig. 5C ). In contrast, forskolin stimulated I (ap)Cl to a greater degree than I (ap)I in nelfinavir-pretreated monolayers, consistent with activation of CFTR (Fig. 5D) . The nelfinavir-potentiated CCh-induced apical anion conductance also displayed sensitivity to inhibition by dithiothreitol (DTT; 2 mM), in contrast to the forskolin-induced conductance (Fig.  5E ). Thus the nelfinavir-enhanced apical membrane Cl Ϫ conductance resembles the Ca 2ϩ -activated Cl Ϫ conductance CaCC, rather than the cAMP-gated CFTR (18). The transient elevation of I sc that typifies muscarinically induced Cl Ϫ secretion in T84 cells is generally attributed to rapid downregulation of apical membrane Cl Ϫ channels by the parallel synthesis of IP 4 and the phosphorylation of the MAP kinase intermediates ERK and p38 (29) (30) (31) . These downregulators of apical Ca 2ϩ -dependent Cl Ϫ conductance render it refractory to further stimulation by Ca 2ϩ -dependent agonists for up to 30 min after withdrawal of muscarinic activation (26) . Downregulation of basolateral membrane K ϩ channels by transactivation of the EGF receptor also follows muscarinic activation in T84 cells and also contributes to the transient nature of CCh-elevated I sc . However, basolateral K ϩ conductance is unaltered in nelfinavir-pretreated cells as shown in Fig.  3, A and B. We therefore tested whether nelfinavir potentiation of apical Cl Ϫ conductance might be explained by inhibition of the muscarinic activation of IP 4 synthesis or by inhibition of phosphorylation of ERK and p38.
We first tested whether nelfinavir had any effect on the refractory period to Ca 2ϩ -dependent agonists observed after muscarinic activation. Control monolayers stimulated with CCh exhibited a typical increase in I sc followed by a rapid return to baseline. There followed a period refractory to subsequent treatment with thapsigargin (Fig. 6A) . In contrast, nelfinavir-pretreated monolayers failed to exhibit such a refractory period after muscarinic stimulation (Fig. 6A) . The nelfinavir-pretreated cells displayed normal sensitivity to thapsigargin exposure only 15 min after the initial exposure to CCh. This response resembles that of cells exposed to thapsigargin without pretreatment with nelfinavir or CCh (Fig. 6A) . The mean results from three independent studies (Fig. 6B) show that nelfinavir abrogates the refractory period seen normally in T84 cells after stimulation with CCh. Despite abolition of the post-CCh-refractory period of T84 cells by nelfinavir pretreatment, nelfinavir had no detectable effect on CCh-induced Western blot of total cell extracts for pERK prepared from intact T84 cell monolayers pretreated with or without the indicated concentrations of nelfinavir and subsequently exposed or not exposed to 100 M CCh for 5 min. Data are representative of 2 independent experiments. D: Western blot of total cell extracts for phospho-p38 prepared from T84 cell monolayers pretreated without (ϪNelfin) or with (ϩNelfin) nelfinavir studied at baseline (lane 2) and after addition of CCh for 0, 0.5, 1, 5, and 15 min (lanes 2-7) . Lane 1 was loaded with phospho-p38. The gel was divided and vertically offset for visual clarity.
E-H: HPLC analyses of [
3 H]IP4 in total cell extracts prepared from control (E and G) or nelfinavir-pretreated monolayers (F and H) and subsequently exposed (G and H) or not to CCh (E and F). IP4 controls were run in parallel (not shown). IP4 levels were similar in control (14,268 dpm) and nelfinavir-pretreated (15,191 dpm) T84 cell monolayers. Data are representative of 2 independent experiments. levels of pERK (Fig. 6C) , phospho-p38 (Fig. 6D) , or IP 4 (Fig.  6, E-H ). These data demonstrate that the Ca 2ϩ -activated Cl Ϫ conductance in nelfinavir-pretreated cells is functionally uncoupled from normal levels of these physiological downregulatory signals.
Nelfinavir potentiates cytosolic [Ca 2ϩ ] i signaling. Because the effects of nelfinavir pretreatment were observed only in cells exposed to Ca 2ϩ -dependent agonists, we examined the effect of nelfinavir on intracellular Ca 2ϩ signaling in fura 2-loaded T84 cells. Nelfinavir itself had no detectable effect on [Ca 2ϩ ] i in resting cells (not shown). After muscarinic stimulation, however, Ca 2ϩ transients in nelfinavir-pretreated cells were increased in magnitude and duration compared with those observed in cells not exposed to nelfinavir (Fig. 7A) . The peak increase in [Ca 2ϩ ] i induced by CCh in nelfinavir-pretreated cells was 138 Ϯ 10 nM (n ϭ 9) vs. 56 Ϯ 4 nM (n ϭ 4; means Ϯ SE) in cells unexposed to nelfinavir. In contrast, nelfinavir pretreatment had no detectable effect on intracellular Ca 2ϩ transients induced by CCh in a Ca 2ϩ -free bath (increase in [Ca 2ϩ ] i : 43 Ϯ 7 vs. 45 Ϯ 5 nM, respectively, n ϭ 3; mean Ϯ SE) (Fig. 7B) (Fig. 8 , n ϭ 3, P Ͻ 0.05). In contrast, the L-type Ca 2ϩ channel blockers verapamil (25 M) and nifedipine (1 M) were without apparent effect on nelfinavir-induced secretory responses (not shown).
Basolateral addition of Ba 2ϩ (3 mM) to T84 monolayers inhibited the enhancement of the muscarine-induced I sc observed in nelfinavir-pretreated monolayers (Fig. 9A) , whereas apical Ba 2ϩ had no effect (not shown). As expected, basolateral application of Ba 2ϩ to untreated monolayers failed to inhibit normal CCh-induced Cl Ϫ secretion ( Fig. 9A ; summarized in Fig. 9B ). Moreover, basolateral Ba 2ϩ did not inhibit the CCh-triggered increase in basolateral K ϩ conductance in apically permeabilized T84 cells pretreated with nelfinavir (Fig. 9, C and D) confirming directly that Ba 2ϩ does not affect IK1 in this experimental system. The inhibitory effect of Ba 2ϩ is also not due to inhibition of the K ϩ channel KCNQ1/ KCNE3, because the chromanol inhibitor of this channel, 293B, similarly had no effect on the potentiation of the CChinduced I sc in intact monolayers pretreated with nelfinavir (not shown might also inhibit the nelfinavir-associated escape from the refractory period that follows muscarinic activation. Indeed, Ba 2ϩ inhibited fully the I sc induced by thapsigargin added soon after muscarinic activation (Fig. 9, E and F) . These data suggest that nelfinavir pretreatment potentiates Ca 2ϩ entry in CCh-stimulated T84 cell monolayers via a mechanism that can be inhibited by basolateral exposure to Ba ] i values 134 Ϯ 58 nM above baseline in nelfinavir-pretreated cells and 108 Ϯ 38 nM in untreated cells (n ϭ 4, mean Ϯ SE) that rapidly returned to baseline levels (Fig. 10, A and B) . Readdition of 2.7 mM extracellular Ca 2ϩ in the continued presence of CCh rapidly increased [Ca 2ϩ ] i to peak values of 229 Ϯ 31 and 183 Ϯ 27 nM above baseline in nelfinavir-pretreated and untreated cells, respectively (n ϭ 4, means Ϯ SE) (Fig. 10, A and B) . However, the rate of the subsequent decline in [Ca 2ϩ ] i in nelfinavir-pretreated cells was much slower than that in untreated cells. [Ca 2ϩ ] i in the absence of nelfinavir fell 78 Ϯ 4% (mean Ϯ SE) from peak values within 8 min after bath Ca 2ϩ readdition (Fig. 10, A and C) . In contrast, [Ca 2ϩ ] i in nelfinavir-pretreated cells decreased only 30 Ϯ 3% from peak levels during the same period (P Ͻ 0.0005; Fig. 10 , B and C). Thus influx-dependent elevation of [Ca 2ϩ ] i following bath Ca 2ϩ readdition to CCh-stimulated T84 cells was prolonged by nelfinavir pretreatment.
After depletion of intracellular Ca 2ϩ stores by thapsigargin exposure of T84 cells in a nominally Ca 2ϩ -free medium, readdition of bath Ca 2ϩ induced an elevation of [Ca 2ϩ ] i larger than that observed after CCh stimulation, with a peak value of 402 Ϯ 11 nM above baseline (n ϭ 4, mean Ϯ SE; Fig. 10D ). This store depletion-activated Ca 2ϩ influx was larger still in nelfinavir-pretreated cells, with a peak value of 816 Ϯ 125 nM above baseline (n ϭ 4, mean Ϯ SE, P Ͻ 0.05; Fig. 10E ).
Moreover, the rate of subsequent [Ca 2ϩ ] i decline in nelfinavirpretreated cells was again much slower than that in untreated cells. Whereas 15 min after bath Ca 2ϩ readdition, [Ca 2ϩ ] i had declined 52 Ϯ 6% from peak values in untreated cells, this decline was only 26 Ϯ 4% in nelfinavir-pretreated cells (means Ϯ SE, P Ͻ 0.0005; Fig. 10F ). Thus nelfinavir pretreatment enhanced both the magnitude and duration of thapsigargin-induced store depletion-activated Ca 2ϩ influx in T84 cells. These data suggest activation by nelfinavir of a store-operated plasmalemmal Ca 2ϩ entry pathway.
DISCUSSION
These studies provide the first mechanistic insights into the pathophysiology of API-induced diarrhea in HIV-infected patients. conductance from normal downregulation by IP 4 , pERK, and phospho-p38. The resulting prolonged activation of apical Cl Ϫ conductance contributes to (and may suffice to explain) the enhanced Cl Ϫ secretory response. This mechanism of action is distinct from that recently proposed for the chemotherapeutic agent flavopiridol, which elicits a secretory response in T84 cells via inhibition of the downregulatory signals affecting the apical Ca 2ϩ -activated Cl Ϫ conductance (27) . On the basis of these results, we propose that nelfinavir acts in vivo directly on the intestinal mucosa to enhance the activity of muscarinic and other Ca 2ϩ -dependent agonists by recruiting an additional store-operated plasmalemmal Ca 2ϩ entry pathway to potentiate an otherwise normal secretory response. Such a mechanism of action on intestinal Cl Ϫ secretion should initiate a secretory form of diarrhea, a prediction confirmed by our clinical studies in hospitalized HIV-infected adults. At peak in vivo plasma concentrations of 6 M for nelfinavir, the (3, 19) . This apical Ca 2ϩ -activated Cl Ϫ conductance is thus a therapeutic target, but specific inhibitors for it and for the cloned CLCA channels remain unidentified. Chlorotoxin, active against the Ca 2ϩ -activated Cl Ϫ conductance of gliomas and astrocytes, appears inactive in T84 cells (33) . Our results also show that nelfinavir effectively uncouples the apical Cl Ϫ conductance from downregulation by the intracellular mediators IP 4 , pERK, and phospho-p38 but has no apparent effect on basolateral K ϩ conductance after muscarinic activation. Thus nelfinavir may elevate levels of intracellular antagonists of these downregulatory signals to potentiate the physiological agonists of Ca 2ϩ -dependent intestinal Cl Ϫ secretion. The reversal potential of thapsigargin-activated apical membrane currents in nelfinavir-pretreated cells (Fig. 5C) suggests that nelfinavir may potentiate in parallel an apical membrane Ca 2ϩ -actived cation conductance and an apical Ca 2ϩ -activated Cl Ϫ conductance, as suggested also by our previous studies in the absence of nelfinavir (34) . Merlin et al. (34) also showed that gluconate permeability of the thapsigargin-induced T84 cell apical membrane conductance is minimal. Similarly, CChinduced increase in I sc across intact, nelfinavir-pretreated T84 cell monolayers is abrogated in nominally Cl Ϫ -free, symmetrical sodium gluconate solutions (not shown). Activation of apical cation currents is consistent with previous reports of nonspecific cation currents in T84 cells (4, 8, 11, 45, 46) .
We have previously shown that the imidazole antifungal clotrimazole and its des-imidazolyl metabolite block intestinal Cl Ϫ secretion by inhibition of both the cAMP-activated K ϩ conductance (likely mediated by KCNQ1/KCNE3) and the Ca 2ϩ -gated K ϩ conductance likely mediated by IK1 (KCNN4) (41) . Blockade of the appropriate K ϩ channel(s) fully inhibits Cl Ϫ secretion induced by either cAMP or Ca 2ϩ -dependent agonists in vitro and by cAMP-dependent agonists in vivo. Basolateral K ϩ channel activity is also required for nelfinavir-stimulated Cl Ϫ secretion by T84 cells and is blocked fully by 30 M clotrimazole, although at this concentration clotrimazole is nonspecific. At the more specific concentration of 1 M, clotrimazole had no effect on CChinduced Cl Ϫ I sc in cells pretreated with nelfinavir or (as previously reported) without nelfinavir (not shown). Clotrimazole has been administered in humans at doses sufficient to block IK1 with minimal toxicity (5, 6) . Thus clotrimazole or other more specific IK1 blockers (16, 44) may be useful for treatment of the secretory diarrhea induced by nelfinavir and other APIs used in the treatment of HIV.
Direct blockade of the nelfinavir-recruited Ca 2ϩ entry pathway, however, might affect more selectively the adverse effects of APIs on regulation of intestinal Cl Ϫ secretion. Such blockade would allow for specific inhibition of API-induced potentiation of Ca 2ϩ -dependent Cl Ϫ secretory responses without affecting the normal muscarine-induced secretory response. Thus molecular identification of this Ca 2ϩ entry pathway might facilitate development of specific inhibitors of this pathway as well as APIs that do not increase its activity.
One family of plasmalemmal Ca 2ϩ -permeable cation channels is the transient receptor potential (TRP) superfamily (9, 36) . TRPV6 (ECaC2/CaT1) and TRPV5 (ECaC1/CaT2) are the most extensively studied TRP channels of the intestine. ECaC2/CaT1 has been localized by in situ hybridization to surface enterocytes of the rat (37) but appears to be absent from human colon (21, 38) . ECaC1/CaT2 has been immunolocalized to the apical membrane of villous tip enterocytes in rabbit duodenum (20) and in transverse and distal colon of the human (21, 38) . In addition, TRPV6 overexpressed in some cultured cells confers increased store-operated cation channel activities. However, the pathway recruited by nelfinavir in T84 cells may represent a basolateral pathway of intestinal crypt cells.
This novel pathway is notable for the ability of Ba 2ϩ to block the nelfinavir-associated enhancement of apical Cl Ϫ secretion as well as for the enhanced magnitude and prolonged duration of muscarinically induced [Ca 2ϩ ] i elevation. In contrast, Ba 2ϩ has no effect on the muscarinically induced I sc in cells not treated with nelfinavir. Thus the inhibitory effect of Ba 2ϩ on nelfinavir-potentiated Cl Ϫ secretion may represent a Ba 2ϩ block of the nelfinavir-induced Ca 2ϩ entry pathway. It is also possible that Ba 2ϩ may permeate the nelfinavir-induced Ca 2ϩ entry pathway. Once inside the cell, Ba 2ϩ might then block a nelfinavir-induced, Ca 2ϩ -dependent reversal of the normal inactivation processes for the apical membrane Ca 2ϩ -activated Cl Ϫ conductance. Thus the molecular identity of the nelfinavir target(s) remains to be determined.
The effects of nelfinavir on Ca 2ϩ signaling in intestinal epithelial cells may similarly apply to other cell types affected by API-based therapeutics. If so, altered Ca 2ϩ signaling in adipocytes, myocytes, or hepatocytes may contribute to other API-associated dose-limiting side effects including lipodystrophy and insulin resistance (13, 43) .
